ArticleNPJ breast cancer2021

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer.

Lillian M Smyth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.